Feature|Videos|April 29, 2024

Alcami: Beyond Expectations

Bill Humphries (CEO, Alcami) dives into an overview of Alcami's capabilities and how they value their client's innovations.

Bill Humphries sat down with Pharmaceutical Technology to highlight the importance of working with Alcami. Learn more about:

  • How Alcami stays ahead of the curve and makes the smart investments in capacity and technology to meet market demand and address sector challenges.
  • Understand Alcami's position to support the future of pharma and biotech, ready with innovative solutions and strategic partnerships that streamline and optimize the path to patients for clients’ therapeutics.
  • Whether clients tap Alcami for one service or seek the benefit of a seamless end-to-end solution, the company’s Lab Services, Drug Product Manufacturing, and Pharma Storage and Services are fully integrated and optimized.

Related to this article

white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.
Green Chemistry Supply and Demand in Sustainable Pharma
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.